|
1
|
Yang S, Mei S, Jin H, Zhu B, Tian Y, Huo
J, Cui X, Guo A and Zhao Z: Identification of two immortalized cell
lines, ECV304 and bEnd3, for in vitro permeability studies of
blood-brain barrier. PLoS One. 12:e01870172017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cecchelli R, Berezowski V, Lundquist S,
Culot M, Renftel M, Dehouck MP and Fenart L: Modelling of the
blood-brain barrier in drug discovery and development. Nat Rev Drug
Discov. 6:650–661. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cardoso FL, Brites D and Brito MA: Looking
at the blood-brain barrier: Molecular anatomy and possible
investigation approaches. Brain Res Rev. 64:328–363. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ronaldson PT and Davis TP: Blood-brain
barrier integrity and glial support: Mechanisms that can be
targeted for novel therapeutic approaches in stroke. Curr Pharm
Des. 18:3624–3644. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu X, Zhu X, Chen M, Ge Q, Shen Y and Pan
S: Resveratrol protects PC12 cells against OGD/R-induced apoptosis
via the mitochondrial-mediated signaling pathway. Acta Biochim
Biophys Sin (Shanghai). 48:342–353. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khatri R, McKinney AM, Swenson B and
Janardhan V: Blood-brain barrier, reperfusion injury, and
hemorrhagic transformation in acute ischemic stroke. Neurology. 79
(13 Suppl 1):S52–S57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Warach S and Latour LL: Evidence of
reperfusion injury, exacerbated by thrombolytic therapy, in human
focal brain ischemia using a novel imaging marker of early
blood-brain barrier disruption. Stroke. 35 (11 Suppl
1):S2659–S2661. 2004. View Article : Google Scholar
|
|
8
|
Zhu H, Wang Z, Xing Y, Gao Y, Ma T, Lou L,
Lou J, Gao Y, Wang S and Wang Y: Baicalin reduces the permeability
of the blood-brain barrier during hypoxia in vitro by increasing
the expression of tight junction proteins in brain microvascular
endothelial cells. J Ethnopharmacol. 141:714–720. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie R, Li X, Ling Y, Shen C, Wu X, Xu W
and Gao X: Alpha-lipoic acid pre- and post-treatments provide
protection against in vitro ischemia-reperfusion injury in cerebral
endothelial cells via Akt/mTOR signaling. Brain Res. 1482:81–90.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao G, Jiang N, Hu Y, Zhang Y, Wang G, Yin
M, Ma X, Zhou K, Qi J, Yu B and Kou J: Ruscogenin attenuates
cerebral ischemia-induced blood-brain barrier dysfunction by
suppressing TXNIP/NLRP3 inflammasome activation and the MAPK
pathway. Int J Mol Sci. 17(pii): E14182016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fu S, Gu Y, Jiang JQ, Chen X, Xu M, Chen X
and Shen J: Calycosin-7-O-β-D-glucoside regulates nitric
oxide/caveolin-1/matrix metalloproteinases pathway and protects
blood-brain barrier integrity in experimental cerebral
ischemia-reperfusion injury. J Ethnopharmacol. 155:692–701. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pillai DR, Shanbhag NC, Dittmar MS,
Boqdahn U and Schlachetzki F: Neurovascular protection by targeting
early blood-brain barrier disruption with neurotrophic factors
after ischemia-reperfusion in rats*. J Cereb Blood Flow Metab.
33:557–566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Plata-Salamán CR: Epidermal growth factor
and the nervous system. Peptides. 12:653–663. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang YF, Cooke MJ, Sachewsky N, Morshead
CM and Shoichet MS: Bioengineered sequential growth factor delivery
stimulates brain tissue regeneration after stroke. J Control
Release. 172:1–11. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu W, Wang P, Shang C, Chen L, Cai H, Ma
J, Yao Y, Shang X and Xue Y: Endophilin-1 regulates blood-brain
barrier permeability by controlling ZO-1 and occludin expression
via the EGFR-ERK1/2 pathway. Brain Res. 1573:17–26. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen L, Liu W, Wang P, Xue Y, Su Q, Zeng C
and Shang X: Endophilin-1 regulates blood-brain barrier
permeability via EGFR-JNK signaling pathway. Brain Res. 1606:44–53.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ronaldson PT and Davis TP: Targeting
blood-brain barrier changes during inflammatory pain: An
opportunity for optimizing CNS drug delivery. Ther Deliv.
2:1015–1041. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wilhelm I and Krizbai IA: In vitro models
of the blood-brain barrier for the study of drug delivery to the
brain. Mol Pharm. 11:1949–1963. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Choi KH, Kim HS, Park MS, Kim JT, Kim JH,
Cho KA, Lee MC, Lee HJ and Cho KH: Regulation of caveolin-1
expression determines early brain edema after experimental focal
cerebral ischemia. Stroke. 47:1336–1343. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo J, Krause DN, Horne J, Weiss JH, Li X
and Duckles SP: Estrogen-receptor-mediated protection of cerebral
endothelial cell viability and mitochondrial function after
ischemic insult in vitro. J Cereb Blood Flow Metab. 30:545–554.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu J, Jin X, Liu KJ and Liu W: Matrix
metalloproteinase-2-mediated occludin degradation and
caveolin-1-mediated claudin-5 redistribution contribute to
blood-brain barrier damage in early ischemic stroke stage. J
Neurosci. 32:3044–3057. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rahman NA, Rasil ANHM, Meyding-Lamade U,
Craemer EM, Diah S, Tuah AA and Muharram SH: Immortalized
endothelial cell lines for in vitro blood-brain barrier models: A
systematic review. Brain Res. 1642:532–545. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ku JM, Taher M, Chin KY, Grace M, McIntyre
P and Miller AA: Characterization of a mouse cerebral microvascular
endothelial cell line (bEnd.3) after oxygen glucose deprivation and
reoxygenation. Clin Exp Pharmacol Physiol. 43:777–786. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Igarashi Y, Utsumi H, Chiba H,
Yamada-Sasamori Y, Tobioka H, Kamimura Y, Furuuchi K, Kokai Y,
Nakagawa T, Mori M and Sawada N: Glial cell line-derived
neurotrophic factor induces barrier function of endothelial cells
forming the blood-brain barrier. Biochem Biophys Res Commun.
261:108–112. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Abbott NJ, Rönnbäck L and Hansson E:
Astrocyte-endothelial interactions at the blood-brain barrier. Nat
Rev Neurosci. 7:41–53. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Basuroy S, Seth A, Elias B, Naren AP and
Rao R: MAPK interacts with occludin and mediates EGF-induced
prevention of tight junction disruption by hydrogen peroxide.
Biochem J. 393:69–77. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park JH and Han HJ: Caveolin-1 plays
important role in EGF-induced migration and proliferation of mouse
embryonic stem cells: Involvement of PI3K/Akt and ERK. Am J Physiol
Cell Physiol. 297:C935–C944. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Campbell M, Collery R, McEvoy A, Gardiner
TA, Stitt AW and Brankin B: Involvement of MAPKs in
endostatin-mediated regulation of blood-retinal barrier function.
Curr Eye Res. 31:1033–1045. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sumanasekera WK, Sumanasekera GU,
Mattingly KA, Dougherty SM, Keynton RS and Klinge CM: Estradiol and
dihydrotestosterone regulate endothelial cell barrier function
after hypergravity-induced alterations in MAPK activity. Am J
Physiol Cell Physiol. 293:C566–C573. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo D, Zhao J and Rong J: Plant-derived
triterpene celastrol ameliorates oxygen glucose deprivation-induced
disruption of endothelial barrier assembly via inducing tight
junction proteins. Phytomedicine. 23:1621–1628. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu D, Mai HC, Liang YB, Xu BD, Xu AD and
Zhang YS: Beneficial role of rosuvastatin in blood-brain barrier
damage following experimental ischemic stroke. Front Pharmacol.
9:9262018. View Article : Google Scholar : PubMed/NCBI
|
